Capital Analysts LLC’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Capital Analysts LLC’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-255	Closed	-$1K	–	1244
2024 Q1	$1K	Hold	255	–	–	﹤0.01%	1108
2023 Q4	$1K	Hold	255	–	–	﹤0.01%	1087
2023 Q3	$4K	Hold	255	–	–	﹤0.01%	1006
2023 Q2	$7K	Sell	255 -13	-5%	-$402	﹤0.01%	863
2023 Q1	$6K	Hold	268	–	–	﹤0.01%	857
2022 Q4	$4K	Hold	268	–	–	﹤0.01%	945
2022 Q3	$6K	Buy	+268	New	+$6.91K	﹤0.01%	877

Other funds holding ASLN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Capital Analysts LLC's ASLN Position: Q2 2024 in Review

Capital Analysts LLC sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q2 2024, closing a stake of 255 shares — an estimated $1K sold.

Capital Analysts LLC first reported a position in ASLN in Q3 2022 and held it in 7 quarters. The position peaked at $7K in Q2 2023. 19 funds tracked by Wall St. Rank hold ASLN as of Q2 2024.

Capital Analysts LLC reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q2 2024 after selling out during the quarter.
Capital Analysts LLC sold 255 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q2 2024, an estimated $1K.
Capital Analysts LLC first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2022 and held it in 7 quarters.
Capital Analysts LLC's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $7K in Q2 2023.
19 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q2 2024.

Based on Capital Analysts LLC's 13F filing for Q2 2024, filed 14 Aug 2024.